BLRX

BioLineRX

26 hedge funds and large institutions have $1.99M invested in BioLineRX in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

less ownership

Funds ownership:

less funds holding

Funds holding:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

33% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 6

61% less capital invested

Capital invested by funds: $5.09M → $1.99M (-$3.1M)

Holders
26
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$37K
Puts
$29K
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$464K
2
$463K
3
$178K
4
$118K
5
$117K
6
$115K
7
$96K
8
$60K
9
$56K
10
$54K
11
$47K
12
$32K
13
$31K
14
$29K
15
$25K
16
$25K
17
$24K
18
$17K
19
$17K
20
$6K
21
$3K
22
$2K
23
$2K
24
$2K
25
$2K